| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |